QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2023     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe 期刊论文 EBIOMEDICINE, 2023, 卷号: 98, 页码: 18 作者:  Wang, Bo;  Tang, Chu;  Lin, En;  Jia, Xiaohua;  Xie, Ganyuan 收藏  |  浏览/下载：4/0  |  提交时间：2024/02/22 Hepatocellular carcinoma  Second near-infrared window  Molecular imaging  HDAC6  Fluorescence guided surgery   Molecular imaging-guided extracellular vesicle-based drug delivery for precise cancer management: Current status and future perspectives 期刊论文 JOURNAL OF CONTROLLED RELEASE, 2023, 卷号: 362, 页码: 97-120 作者:  Cheng, Zhongquan;  Shang, Jihuan;  Wang, Huarong;  Yu, Leyi;  Yuan, Zhu 收藏  |  浏览/下载：9/0  |  提交时间：2023/11/16 Extracellular vesicles  Molecular imaging  Cancer  Diagnosis  Therapy   Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文 BMC CANCER, 2023, 卷号: 23 作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping 收藏  |  浏览/下载：4/0  |  提交时间：2023/11/10 Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival   Bioimaging of glutathione variation for early diagnosis of hepatocellular carcinoma using a liver-targeting ratiometric near-infrared fluorescent probe 期刊论文 JOURNAL OF MATERIALS CHEMISTRY B, 2023, 页码: 9 作者:  Han, Xiaoyue;  Xing, Yanlong;  Song, Xinyu;  Dou, Kun;  Yu, Fabiao 收藏  |  浏览/下载：1/0  |  提交时间：2024/01/26 Wnt Signaling Pathway Collapse upon beta-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using Breast Cancer Cell Lines 期刊论文 MOLECULES, 2023, 卷号: 28, 期号: 3, 页码: 1 作者:  Selvarathinam, Kanitha;  Subramani, Prabhu;  Thekkumalai, Malarvili;  Vilwanathan, Ravikumar;  Selvarajan, Ramganesh 收藏  |  浏览/下载：16/0  |  提交时间：2023/04/14 antimicrobial peptides  anticancer agents  breast cancer  Wnt pathway  beta-catenin  downregulation  oncology  alternative therapy